Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.198
Companies that carry out R&D in Biotechnology	Main	644
Companies that carry out R&D in Biotechnology	Secondary dwellings	171
Companies that carry out R&D in Biotechnology	Tool	383
%Companies according to biotechnology used: Genetic code	Total	33,3
%Companies according to biotechnology used: Genetic code	Main	40,9
%Companies according to biotechnology used: Genetic code	Secondary dwellings	24
%Companies according to biotechnology used: Genetic code	Tool	24,8
%Companies according to biotechnology used: Functional units	Total	39,8
%Companies according to biotechnology used: Functional units	Main	44,2
%Companies according to biotechnology used: Functional units	Secondary dwellings	38,1
%Companies according to biotechnology used: Functional units	Tool	33,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	24,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	28,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	14,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	20,8
%Companies according to biotechnology used: Bioprocesses	Total	49,6
%Companies according to biotechnology used: Bioprocesses	Main	42,6
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	52,3
%Companies according to biotechnology used: Bioprocesses	Tool	60,2
%Companies according to biotechnology used: Sub-cellular organisms	Total	6,7
%Companies according to biotechnology used: Sub-cellular organisms	Main	8,7
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	5,8
%Companies according to biotechnology used: Sub-cellular organisms	Tool	3,6
%Companies according to biotechnology used: Bio-computing	Total	23,9
%Companies according to biotechnology used: Bio-computing	Main	33,5
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	13
%Companies according to biotechnology used: Bio-computing	Tool	12,7
%Companies according to biotechnology used: Nanobiotechnology	Total	11,2
%Companies according to biotechnology used: Nanobiotechnology	Main	14,5
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	13,4
%Companies according to biotechnology used: Nanobiotechnology	Tool	4,7
%Companies according to biotechnology used: Other	Total	14,6
%Companies according to biotechnology used: Other	Main	14,4
%Companies according to biotechnology used: Other	Secondary dwellings	19,9
%Companies according to biotechnology used: Other	Tool	12,6
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	47,3
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	62,8
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	35,1
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	26,7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	19,4
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	21,7
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	17,8
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	16,2
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	32,5
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	26,1
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	30,5
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	44,1
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	24,1
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	20,7
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	31,8
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	26,5
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	14,9
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	12,8
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	28,9
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	12,3
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	12,8
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	12,8
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	17,8
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	10,6
Personnel in R&D in biotechnology (no. of persons)	Total	13.615
Personnel in R&D in biotechnology (no. of persons)	Main	8.038
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.812
Personnel in R&D in biotechnology (no. of persons)	Tool	3.765
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	7.436
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	4.561
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	1.031
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	1.845
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	6.178
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	3.477
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	781
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	1.920
Personnel in R&D in biotechnology (no. of persons): women	Total	7.639
Personnel in R&D in biotechnology (no. of persons): women	Main	4.718
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	918
Personnel in R&D in biotechnology (no. of persons): women	Tool	2.003
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	4.095
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	2.582
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	540
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	973
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	3.544
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	2.136
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	378
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	1.030
Personnel in R&D in biotechnology (FTE)	Total	9.365,2
Personnel in R&D in biotechnology (FTE)	Main	5.985,1
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	1.120,4
Personnel in R&D in biotechnology (FTE)	Tool	2.259,7
Personnel in R&D in biotechnology (FTE): Researchers	Total	5.410,6
Personnel in R&D in biotechnology (FTE): Researchers	Main	3.550,1
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	695,8
Personnel in R&D in biotechnology (FTE): Researchers	Tool	1.164,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	3.954,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	2.435
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	424,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	1.095
Personnel in R&D in biotechnology (FTE): women	Total	5.385,8
Personnel in R&D in biotechnology (FTE): women	Main	3.561,4
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	597,6
Personnel in R&D in biotechnology (FTE): women	Tool	1.226,7
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	3.032,9
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	2.028,8
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	372,1
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	632
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	2.352,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.532,6
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	225,6
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	594,7
Internal expenditure on R&D (thousands of euros)	Total	940.230
Internal expenditure on R&D (thousands of euros)	Main	671.106
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	84.012
Internal expenditure on R&D (thousands of euros)	Tool	185.112
1) By nature of the expense: Current expenses	Total	871.813
1) By nature of the expense: Current expenses	Main	624.784
1) By nature of the expense: Current expenses	Secondary dwellings	75.356
1) By nature of the expense: Current expenses	Tool	171.672
1.1) Remuneration to researchers	Total	284.936
1.1) Remuneration to researchers	Main	194.490
1.1) Remuneration to researchers	Secondary dwellings	33.985
1.1) Remuneration to researchers	Tool	56.460
1.2) Remuneration to technicians and assistants	Total	148.254
1.2) Remuneration to technicians and assistants	Main	96.140
1.2) Remuneration to technicians and assistants	Secondary dwellings	14.239
1.2) Remuneration to technicians and assistants	Tool	37.875
1.3) Other current expenses	Total	438.623
1.3) Other current expenses	Main	334.154
1.3) Other current expenses	Secondary dwellings	27.132
1.3) Other current expenses	Tool	77.337
2) By nature of the expense: Capital expenses	Total	68.417
2) By nature of the expense: Capital expenses	Main	46.322
2) By nature of the expense: Capital expenses	Secondary dwellings	8.656
2) By nature of the expense: Capital expenses	Tool	13.440
2.1) Land and buildings	Total	11.763
2.1) Land and buildings	Main	6.204
2.1) Land and buildings	Secondary dwellings	2.874
2.1) Land and buildings	Tool	2.685
2.2) Equipment and instruments	Total	39.641
2.2) Equipment and instruments	Main	24.588
2.2) Equipment and instruments	Secondary dwellings	5.378
2.2) Equipment and instruments	Tool	9.674
2.3) Acquisition of specific R+D software	Total	2.831
2.3) Acquisition of specific R+D software	Main	1.735
2.3) Acquisition of specific R+D software	Secondary dwellings	319
2.3) Acquisition of specific R+D software	Tool	777
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	14.183
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	13.794
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	85
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	303
1.1) By origin of the funds: Own funds	Total	577.287
1.1) By origin of the funds: Own funds	Main	421.224
1.1) By origin of the funds: Own funds	Secondary dwellings	39.177
1.1) By origin of the funds: Own funds	Tool	116.886
1.2) By origin of the funds: From companies	Total	142.672
1.2) By origin of the funds: From companies	Main	96.993
1.2) By origin of the funds: From companies	Secondary dwellings	8.211
1.2) By origin of the funds: From companies	Tool	37.467
1.3) By origin of the funds: Public Administration funds	Total	102.630
1.3) By origin of the funds: Public Administration funds	Main	64.741
1.3) By origin of the funds: Public Administration funds	Secondary dwellings	18.219
1.3) By origin of the funds: Public Administration funds	Tool	19.670
1.4) By origin of the funds: From Universities	Total	457
1.4) By origin of the funds: From Universities	Main	453
1.4) By origin of the funds: From Universities	Secondary dwellings	0
1.4) By origin of the funds: From Universities	Tool	5
1.5) By origin of the funds: From non profit private institutions	Total	9.631
1.5) By origin of the funds: From non profit private institutions	Main	8.141
1.5) By origin of the funds: From non profit private institutions	Secondary dwellings	195
1.5) By origin of the funds: From non profit private institutions	Tool	1.294
1.6) By origin of the funds: Foreign funds	Total	107.553
1.6) By origin of the funds: Foreign funds	Main	79.554
1.6) By origin of the funds: Foreign funds	Secondary dwellings	18.210
1.6) By origin of the funds: Foreign funds	Tool	9.790
Purchase of R&D services in biotechnology (thousands of euros)	Total	114.839
Purchase of R&D services in biotechnology (thousands of euros)	Main	87.621
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	15.855
Purchase of R&D services in biotechnology (thousands of euros)	Tool	11.363
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	69.258
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	50.862
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	13.073
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	5.324
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	45.581
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	36.760
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	2.782
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	6.039
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	41,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	48,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	36,1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	33
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	9,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	16,6
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	14,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	13,1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	11,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	14,8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	10,7
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	10,8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	10,3
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	10,5
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	15
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	15
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	12
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	15
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	19
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	17
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	41
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	38
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	31
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	51
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	50
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	43
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	17,4
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	18,9
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	21,8
% Companies that have requested biotechnology patents	Total	18
% Companies that have requested biotechnology patents	Main	26
% Companies that have requested biotechnology patents	Secondary dwellings	14
% Companies that have requested biotechnology patents	Tool	8
Number of patents requested	Total	643
Number of patents requested	Main	471
Number of patents requested	Secondary dwellings	54
Number of patents requested	Tool	118
% Companies with income of an international origin related to biotechnological activities	Total	24,4
% Companies with income of an international origin related to biotechnological activities	Main	30,7
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	15,3
% Companies with income of an international origin related to biotechnological activities	Tool	17,9
% Turnover representing income of an international origin related to biotechnological activities	Total	1,6
% Turnover representing income of an international origin related to biotechnological activities	Main	8,5
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0
% Turnover representing income of an international origin related to biotechnological activities	Tool	1,5
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	56
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	61
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	60
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	40
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	44
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	39
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	40
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	60
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	70
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	79
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	73
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	44
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	23,9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	18,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	0,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	41,4
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	5,3
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	1,9
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	26,7
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	14,5
% Income of an international origin related with activities according to the classification: Other	Total	0,6
% Income of an international origin related with activities according to the classification: Other	Main	0,8
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0
% Income of an international origin related with activities according to the classification: Other	Tool	0,1